Role of invasive EP testing in the evaluation and management of hypertrophic cardiomyopathy

Cardiac Electrophysiology Review

Volumn 6, Issue 4, 2002, Pages 482-486

  Behr, Elijah R ^a   Elliott, Perry ^a   McKenna, William J ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Electrophysiological testing; Hypertrophic cardiomyopathy; Sudden death; Ventricular arrhythmias

Indexed keywords

ARRHYTHMOGENESIS; ARTIFICIAL HEART PACEMAKER; BLOOD PRESSURE; CARDIOVASCULAR RISK; CATHETER ABLATION; COHORT ANALYSIS; DISEASE SEVERITY; FAMILY HISTORY; HEART ARREST; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART STIMULATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HIGH RISK POPULATION; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; PATIENT CARE; PRIMARY PREVENTION; PROGNOSIS; REVIEW; RISK FACTOR; SUDDEN DEATH; SURVIVAL RATE; SURVIVAL TIME; SYNCOPE; WOLFF PARKINSON WHITE SYNDROME;

CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; ELECTROPHYSIOLOGY; FEMALE; HEART ARREST; HUMANS; MALE; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR;

EID: 0036953473     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021161114347     Document Type: Review

References (31)

1. Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation 1997;96(9):2987-2991.
2. Maron BJ, Savage DD, Wolfson JK, Epstein SE. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study. Am J Cardiol 1981;48(2):252-257.
3. McKenna WJ, Oakley CM, Krikler DM, Goodwin JF. Improved survival with amiodarone in patients with hypertrophic: cardiomyopathy and ventricular tachycardia. Br Heart J 1985;53(4):412-416.
4. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981;47(3):532-538.
5. Elliott PM, Gimeno BJ, Mahon NG, Poloniecki JD, McKenna WJ. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 2001;357(9256):420-424.
6. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342(24):1778-1785.
7. Elliott PM, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A, McKenna WJ. Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients. J Am Coll Cardiol 2000;36(7):2212-2218.
8. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort [published erratum appears in JAMA 1999;281(24):22881. JAMA 1999;281(7):650-655.
9. Monserrat L, Elliott PM, Penas Lado M, Castro Beiras A, McKenna WJ. Prognostic value of non-sustained ventricular tachycardia in adult patients with hypertrophic cardiomyopathy. European Heart Journal 1999;20:17, Abstract.
10. Nicod P, Polikar R, Peterson KL. Hypertrophic cardiomyopathy and sudden death. N Engl J Med 1988; 318(19):1255-1257.
11. Stafford WJ, Trohman RG, Bilsker M, Zaman L, Castellanos A, Myerburg RJ. Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;7(3):701-704.
12. Krikler DM, Davies MJ, Rowland E, Goodwin JF, Evans RC, Shaw DB. Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J 1980;43(3):245-251.
13. McKenna WJ, Camm AJ. Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation 1989;80(5):1489-1492.
14. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA, Spirito P. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000;342(6):365-373.
15. Ingham RE, Mason JW, Rossen RM, Goodman DJ, Harrison DC. Electrophysiologic findings in patients with idiopathic hypertrophic subaortic: stenosis. Am J Cardiol 1978;41(5):811-816.
16. Fananapazir L, Tracy CM, Leon MB, Winkler JB, Cannon RO, Bonow RO, Maron BJ, Epstein SE. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation 1989;80(5):1259-1268.
17. Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992;86(3):730-740.
18. Wellens HJ, Brugada P, Stevenson WG. Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: What is the significance of induced arrhythmias and what is the correct stimulation protocol? Circulation 1985;72(1):1-7.
19. Wellens HJ, Brugada P, Stevenson WG. Programmed electrical stimulation of the heart in patients with life-threatening ventricular arrhythmias: What is the significance of induced arrhythmias and what is the correct stimulation protocol? Circulation 1985;72(1):1-7.
20. Saumarez RC, Slade AK, Grace AA, Sadoul N, Camm AJ, McKenna WJ. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study. Circulation 1995;91(11):2762-2768.
21. Kuck KH, Kunze KP, Schluter M, Nienaber CA, Costard A. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. Eur Heart J 1988;9(2):177-185.
22. Saumarez RC, Camm AJ, Panagos A, Gill JS, Stewart JT, de Belder MA, Simpson IA, McKenna WJ. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation 1992;86(2):467-474.
23. MacRae CA, Ghaisas N, Kass S, Donnelly S, Basson CT, Watkins HC, Anan R, Thierfelder LH, McGarry K, Rowland E. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 1995;96(3):1216-1220.
24. Blair E, Redwood C, Ashrafian H, Oliveira M, Broxholme J, Kerr B, Salmon A, Ostman-Smith I, Watkins H. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic: cardiomyopathy: Evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet 2001;10(11):1215-1220.
25. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Hassan AS Ahmad F, Lozado R, Shah G, Fananapazir L, Bachinski LL, Roberts R. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 2001;344(24):1823-1831.
26. Arad M, Benson DW, Perez-Atayde AR, McKenna WJ, Sparks EA, Kanter RJ McGarry K, Seidman JG, Seidman CE. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 2002;109(3):357-362.
27. Madariaga I, Carmona JR, Mateas FR, Lezaun R, de los A.E. Supraventricular arrhythmia as the cause of sudden death in hypertrophic cardiomyopathy. Eur Heart J 1994;15(1):134-137.
28. Manolis AG, Katsivas AG, Lazaris EE, Vassilopoulos CV, Louvros NE. Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias. J Interv Card Electrophysiol 1998;2(1):71-76.
29. Alfonso F, Frenneaux MP, McKenna WJ. Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: Association with left ventricular apical aneurysm. Br Heart J 1989;61(2):178-181.
30. Rodriguez LM, Smeets JL, Timmermans C, Blommaert D, van Dantzig JM, de Muinck EB, Wellens HJ. Radiofrequency catheter ablation of sustained monomorphic ventricular tachycardia in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 1997;8(7):803-806.
31. Mantica M, Della BP, Arena V. Hypertrophic cardiomyopathy with apical aneurysm: A case of catheter and surgical therapy of sustained monomorphic ventricular tachycardia. Heart 1997;77(5):481-483.